Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • OKLO vs GSK✓SelectedUSD · GSKOKLO vs GSK performance historyLatest closeAs of-4.75%11/20
Stock and ETF performance explorer

OKLO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+92.3%
GSK return
+53.4%
Excess return
+39.0%
Maximum drawdown
-89.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.8%-0.1%-4.6%-4.8%
7D-17.0%-5.3%-11.7%-17.2%
30D-28.4%-3.7%-24.8%-28.4%
3M-52.4%-7.3%-45.1%-52.4%
6M-68.3%-4.2%-64.0%-68.2%
YTD-72.3%+0.9%-73.2%-72.0%
1Y-77.4%+7.3%-84.7%-77.1%
3Y+92.3%+52.7%+39.6%+83.7%
All+92.3%+53.4%+39.0%+83.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling